Newcastle disease virus and duck circovirus fusion protein as well as coding gene and application thereof
A technology of duck circovirus and Newcastle disease virus, applied in gene therapy, antiviral agents, virus antigen components, etc., can solve the problems of DNA vaccines that have not been reported
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0041] Example 1. Construction and expression identification of recombinant eukaryotic expression vector pcDNA3.1-F-Cap
[0042]1. Acquisition of the F gene of duck-derived Newcastle disease virus and the Cap gene of duck circovirus
[0043] 1. Design and synthesis of primers
[0044] According to the F gene sequence of duck Newcastle disease virus (DuNDV) and the Cap gene sequence of duck circovirus (DuCV), primers were designed and synthesized (Table 1). Among them, primers F1 and F2 were used to amplify the ORF of the F gene of duck-derived NDV, primers C1 and C2 were used to amplify the ORF of the Cap gene of DuCV, and the four primers carried HindⅢ, BamHI, BamHI and EcoRI restriction sites respectively ( part in italics). The linker is underlined, and the wavy line is the kozak sequence. Primers were synthesized by Shanghai Invitrogen Company.
[0045] The primer sequence of table 1F gene and Cap gene
[0046]
[0047] 2. Nucleic acid extraction and target gene am...
Embodiment 2
[0080] Embodiment 2, animal immunization and antibody detection
[0081] 1. Grouping and immunization of test ducks
[0082]40 two-week-old SPF ducklings were randomly divided into 4 groups, 10 in each group. Blood was collected from ducks in each group before inoculation, and serum was separated. In the first group, each SPF duck was immunized with 100 μg of the recombinant plasmid pcDNA3.1-F-Cap constructed in Example 1; in the second group, each SPF duck was immunized with 200 μg of the recombinant plasmid pcDNA3.1-F-Cap; in the third group, each SPF duck was immunized with recombination Plasmid pcDNA3.1-F-Cap300μg; the fourth group (empty vector control group) immunized each SPF duck with 300μg of pcDNA3.1(+) empty vector. Immunization was performed by multiple injections into the chest muscles. Two weeks after the first immunization, a booster immunization with the same dose as the first immunization was carried out, blood was collected two weeks after each immunizatio...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com